Competitiveness in Healthcare industries
The objective of the work of the Enterprise and Industry Directorate-General in the Healthcare Industries is to develop and maintain a favourable environment in the European Union, which guarantees a high level of protection of public health, contributes to the completion of the Single Market for Pharmaceuticals and Medical Devices and fosters a stable and predictable environment for Innovation and Competitiveness.
Despite numerous achievements over the past few years, Europe is confronted today with major health, economic and scientific challenges. Our objective is to identify the key issues which adversely affect the competitiveness of European healthcare industries and to propose and implement solutions in cooperation with the relevant stakeholders.
Our activities therefore focus on the economic aspects of the sector, in particular the performance of industrial actors and the interactions between research, product development, market access, competition in the market and trade.
More information relating to regulatory issues
|Process on Corporate responsibility||Pricing & reimbursement of Medicinal products||Pharmaceutical Forum||Information to patients: non-legislative approach||Pharmaceutical Industry: a strategic sector|